Skeletal-related events and mortality among older men with advanced prostate cancer

Journal of Geriatric Oncology

Volumn 5, Issue 3, 2014, Pages 281-289

  Onukwugha, Eberechukwu ^a   Yong, Candice ^a   Mullins, C Daniel ^a   Seal, Brian ^b   McNally, Diane ^a   Hussain, Arif ^c,d  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b Bayer HealthCare Pharmaceuticals Inc   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

Bone surgery; Fractures; Health services research; Prostatic neoplasms; Spinal cord compression; Survival

Indexed keywords

ADVANCED CANCER; AGED; ARTICLE; BONE METASTASIS; CANCER MORTALITY; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCULOSKELETAL DISEASE; ORTHOPEDIC SURGERY; PATHOLOGIC FRACTURE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; SKELETAL RELATED EVENT; SPINAL CORD COMPRESSION; BONE TUMOR; COST OF ILLNESS; EPIDEMIOLOGY; PROSTATE TUMOR; SECONDARY; SPINAL CORD TUMOR; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BONE NEOPLASMS; COST OF ILLNESS; EPIDEMIOLOGIC METHODS; FRACTURES, SPONTANEOUS; HUMANS; MALE; PROSTATIC NEOPLASMS; SPINAL CORD COMPRESSION; SPINAL NEOPLASMS; UNITED STATES;

EID: 84904964131     PISSN: 18794068     EISSN: 18794076     Source Type: Journal    
DOI: 10.1016/j.jgo.2014.03.002     Document Type: Article

References (25)

1. ACS Cancer facts & figures 2013 2013, American Cancer Society, Atlanta.
2. Droz J.P., Balducci L., Bolla M., Emberton M., Fitzpatrick J.M., Joniau S., et al. Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology. BJU Int 2010 Aug, 106(4):462-469.
3. ACS Bone metastasis [cited 2013 March 23]; Available from:. http://www.cancer.org/acs/groups/cid/documents/webcontent/003087-pdf.pdf.
4. Schulman K.L., Kohles J. Economic burden of metastatic bone disease in the U.S. Cancer Jun 1 2007, 109(11):2334-2342.
5. Coleman R.E. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res Oct 15 2006, 12(20 Pt 2):6243s-6249s.
6. Norgaard M., Jensen A.O., Jacobsen J.B., Cetin K., Fryzek J.P., Sorensen H.T. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007). J Urol Jul 2010, 184(1):162-167.
7. Saad F., Olsson C., Schulman C.C. Skeletal morbidity in men with prostate cancer: quality-of-life considerations throughout the continuum of care. Eur Urol Dec 2004, 46(6):731-739. [discussion 9-40].
8. Weinfurt K.P., Li Y., Castel L.D., Saad F., Timbie J.W., Glendenning G.A., et al. The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer. Ann Oncol Apr 2005, 16(4):579-584.
9. Damber J.E., Aus G. Prostate cancer. Lancet May 17 2008, 371(9625):1710-1721.
10. Oefelein M.G., Ricchiuti V., Conrad W., Resnick M.I. Skeletal fractures negatively correlate with overall survival in men with prostate cancer. J Urol Sep 2002, 168(3):1005-1007.
11. Saad F., Lipton A., Cook R., Chen Y.M., Smith M., Coleman R. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer Oct 15 2007, 110(8):1860-1867.
12. Sathiakumar N., Delzell E., Morrisey M.A., Falkson C., Yong M., Chia V., et al. Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999-2006. Prostate Cancer Prostatic Dis Jun 2011, 14(2):177-183.
13. AJCC Manual for staging of cancer 1988, Lippincott, [editor]. 3rd ed.
14. AJCC Manual for staging of cancer 2002, Lippincott, [editor]. 6th ed.
15. Curtis J.R., Mudano A.S., Solomon D.H., Xi J., Melton M.E., Saag K.G. Identification and validation of vertebral compression fractures using administrative claims data. Med Care Jan 2009, 47(1):69-72.
16. Lix L.M., Azimaee M., Osman B.A., Caetano P., Morin S., Metge C., et al. Osteoporosis-related fracture case definitions for population-based administrative data. BMC Public Health 2012, 12:301.
17. Barlev A., Song X., Ivanov B., Setty V., Chung K. Payer costs for inpatient treatment of pathologic fracture, surgery to bone, and spinal cord compression among patients with multiple myeloma or bone metastasis secondary to prostate or breast cancer. J Manag Care Pharm Nov-Dec 2010, 16(9):693-702.
18. Prentice R.L., Gloeckler L.A. Regression analysis of grouped survival data with application to breast cancer data. Biometrics Mar 1978, 34(1):57-67.
19. Nieto F.J., Coresh J. Adjusting survival curves for confounders: a review and a new method. Am J Epidemiol May 15 1996, 143(10):1059-1068.
20. Rosenbaum P.R., Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 1983, 70(1):41-55.
21. Parsons L. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. 26th annual SAS users' group international conference 2001.
22. Giordano S.H., Kuo Y.F., Duan Z., Hortobagyi G.N., Freeman J., Goodwin J.S. Limits of observational data in determining outcomes from cancer therapy. Cancer Jun 2008, 112(11):2456-2466.
23. Shahinian V.B., Kuo Y.F. Patterns of bone mineral density testing in men receiving androgen deprivation for prostate cancer. J Gen Intern Med 2013 Nov, 28(11):1440-1446.
24. Morgans A.K., Smith M.R., O'Malley A.J., Keating N.L. Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy. Cancer Feb 15 2012, 119(4):863-870.
25. Fizazi K., Carducci M., Smith M., Damiao R., Brown J., Karsh L., et al. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet Mar 5 2011, 377(9768):813-822.